Correlation Between Milestone Pharmaceuticals and Alvotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Alvotech, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Alvotech.

Diversification Opportunities for Milestone Pharmaceuticals and Alvotech

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Milestone and Alvotech is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Alvotech go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and Alvotech

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.95 times more return on investment than Alvotech. However, Milestone Pharmaceuticals is 1.95 times more volatile than Alvotech. It trades about 0.13 of its potential returns per unit of risk. Alvotech is currently generating about 0.01 per unit of risk. If you would invest  170.00  in Milestone Pharmaceuticals on September 18, 2024 and sell it today you would earn a total of  12.00  from holding Milestone Pharmaceuticals or generate 7.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  Alvotech

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Alvotech 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Alvotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Milestone Pharmaceuticals and Alvotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and Alvotech

The main advantage of trading using opposite Milestone Pharmaceuticals and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.
The idea behind Milestone Pharmaceuticals and Alvotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities